Treatment progress of acute myeloid leukemia / 白血病·淋巴瘤

ABSTRACT

At the 61st American Society of Hematology Annual Meeting in 2019, the research progress and clinical trial updates on basic research, clinical treatment and development of new drugs in acute myeloid leukemia are reported. Based on the meeting report, this article introduces the relevant research progress of the prognosis of acute myeloid leukemia and "7+3" regimen induction therapy, demethylation drugs and targeted therapy.